Centene (CNC) is higher today as the managed-care group catches a bid following policy-driven relief around Medicare Advantage reimbursement. CMS finalized a net average 2.48% payment increase for Medicare Advantage plans for calendar year 2027—more than $13 billion in incremental payments—easing fears that 2027 rates would be essentially flat and improving the tone across the sector. (cms.gov)

Rate clarity can reset near-term expectations for health insurers’ pricing and benefit design, and it tends to ripple across the group even when individual company exposure differs. With managed-care stocks having been pressured by medical-cost trend uncertainty and government-program headwinds, the rate surprise has acted as a macro catalyst to de-risk the outlook and prompt short-covering and re-risking in beaten-down names. (spglobal.com)

Centene is also approaching a near-term catalyst: it is scheduled to release first-quarter 2026 results on April 28, 2026. With the stock still sensitive to policy and margin narratives, investors will focus on any commentary about 2026 execution (including marketplace and Medicaid trends) and whether management reiterates or adjusts its 2026 adjusted diluted EPS guidance of greater than $3.00. (finance.yahoo.com)